Skip to main content
STXS logo

STXS · Stereotaxis, Inc.

Track STXS — free
$1.38 +0.00 (+0.00%) At close · Aug 14
Market Cap
$138.28M
Shares
100.20M

Price & Indicators

20d MA 50d MA 200d MA Earnings Filing Insider Congress Investor day
Close$1.38 Open$1.41 Day$1.33–1.41 52W close$1.26–3.57 Avg vol 30d1.2M Short int4.5M · 4.5% float · 2.5d Short vol54% Last earningsAug 11, 2026 DataJan 2020–Aug 2026 Filing10-Q · Aug 12

Up next

Next earnings call
Nov 23, 2026 Est · unconfirmed · in 14 wks
FQ3-26 quarter ends
~Sep 30, 2026 Est
filed Aug 12, 2026

AI Brief

TL;DR.

Bullish
    Bearish

      AI-generated from the earnings call and 8-K · may contain errors · not investment advice

      Ask ALVIS about this →

      Equibles Rating

      blended score · not investment advice
      Overall
      Sell
      SellHoldBuy
      Technical Sell Momentum Very Weak Sentiment Bearish Fundamentals Strong Quant / Vol Very High
      Market backdrop VIX 14.3 · calm Equity put/call 0.52
      Technical
      price trend
      Sell
      50 / 200-day cross No cross
      Price vs 200-day avg −33%
      below
      Price vs 50-day avg −14%
      below
      RSI (14) 42
      neutral
      MACD trend Positive
      52-week position 5%
      near low
      Volume (OBV) Confirms
      volume backs price
      Momentum
      relative strength
      Very Weak
      1-month return −11%
      trailing
      6-month return −36%
      trailing
      YTD return −40%
      this year
      Relative strength −49%
      vs S&P · 6-mo
      Sentiment
      smart money
      Bearish
      Trend (MA cross) No cross
      50d $2 › 200d $2 — 200d above 50d
      Institutional flow Distributing
      -9% holders QoQ · +13 funds added
      Insider flow Flat
      No net insider activity over 90 days
      Short interest Rising
      4.47% of float · ▲ +0.5% MoM · 2.5 days cover
      Volume signal Normal
      Volume near normal
      Institution breadth Steady
      107 holders — mid 3-yr range
      Squeeze score 51
      elevated · 0–100
      Fundamentals
      Strong
      Revenue growth −6%
      Y/Y
      Gross margin 58%
      expanding
      EPS growth +17%
      Y/Y
      Balance sheet $12.4M
      net cash
      Quant / Vol
      risk profile
      Very High
      Volatility 54%
      annualized · 1-yr
      Max drawdown −65%
      past year
      ATR 7.6%
      of price · 14-day

      Blended from price, momentum, positioning, fundamentals & volatility · daily-close · not investment advice. Market backdrop is context, not part of the score.

      Guidance & track record

      Latest guidance · from the 8-K filed Aug 11, 2026
      third quarter
      Recurring revenue $7M
      System revenue $3M
      fourth quarter
      System revenue $3M
      Prior guidance period ended · from the 8-K filed Nov 12, 2025
      Revenue · fourth quarter of this year at least $9M
      Recurring revenue · fourth quarter of this year at least $6M
      Guided vs delivered · last 1 settled
      Revenue fourth quarter of this year
      guided at least $9M
      $8.64M Miss −4.0%

      Guidance from company 8-Ks · delivered figures from as-reported statements · no analyst estimates involved.

      Technicals

      trend & momentum for long-term holders Sell
      3 · 3 · 1
      50 / 200-day cross
      No cross Neutral
      Price vs 200-day avg
      −33% Bearish
      Price vs 50-day avg
      −14% Bearish
      RSI (14)
      42 Neutral
      MACD trend
      Positive Bullish
      52-week position
      5% Bearish
      Volume (OBV)
      Confirms Neutral
      Market signals — smart money & positioning
      Bearish · 2 of 6
      Trend (MA cross) No cross
      50d $2 › 200d $2 — 200d above 50d
      Institutional flow Distributing
      -9% holders QoQ · +13 funds added
      Insider flow Flat
      No net insider activity over 90 days
      Short interest Rising
      4.47% of float · ▲ +0.5% MoM · 2.5 days cover
      Volume signal Normal
      Volume near normal
      Institution breadth Steady
      107 holders — mid 3-yr range
      Price context
      position in its 52-week range
      Range low $1 Now $1 · 5% Range high $4
      vs 200-day avg -33% vs 50-day avg -14%

      Illustrative technical + ownership context — a signal mix, not investment advice.

      Key metrics

      the company's own KPIs, from written earnings releases and filings
      Metric Latest Period YoY
      Free cash flow -$3.7M Q2 2026
      System backlog $9.1M the start of 2026

      Figures exactly as the company stated them in writing · click a metric with a to chart its history · period links open the stating document · "filing" marks figures stated in the 10-K/10-Q · YoY needs an exactly comparable prior-year period

      Versus peers

      Medical Instruments & Supplies — same industry group
      Open screener →
      Company Mkt cap YTD Rev growth Y/Y P/E Short % shares
      STXS
      Stereotaxis, Inc.
      this stock
      $138.28M -40.0% -5.8% 4.5%
      ISRG
      Intuitive Surgical Inc
      $139.37B -30.3% +20.5% 45.3 1.9%
      BDX
      Becton Dickinson & Co
      $49.96B +8.2% 3.7%
      MDLN
      Medline Inc.
      $46.99B -14.9% +11.5% 2.6%
      ALC
      Alcon Inc
      $35.97B -5.8% +10.5% 2.8%

      Peers by industry group · P/E from as-reported trailing EPS · short % is of shares outstanding

      At a glance

      key data from every section
      Ownership
      Institutional Holders Reducing
      Holders
      107
      % held
      39.6%
      Net QoQ
      -3.3M sh
      Top holder
      DAFNA Capital Management…
      Held Float
      View
      Held by Funds
      Fund positions
      85
      View
      Short & Settlement
      Short Interest Rising
      Shares short
      4.5M
      Days to cover
      2.5d
      Change
      +23.9K sh
      View
      Short Volume
      Short vol %
      54%
      As of
      Aug 14, 2026
      Short Total
      View
      Fails to Deliver
      FTD shares
      22.9K
      Value
      $37.6K
      As of
      Jul 14, 2026
      View
      Off-Exchange
      Off-exchange %
      69.5%
      Week of
      Jul 6, 2026
      Off-exch Lit
      View
      Financials
      Financials
      Revenue (FY)
      $32.4M
      Net income (FY)
      $-21.6M
      EPS diluted
      $-0.25
      View
      Filings
      SEC Filings
      Latest
      10-Q
      Filed
      Aug 12, 2026
      This year
      12
      View
      Exempt Offerings
      Offering
      Indefinite
      Filed
      Aug 15, 2024
      View
      Earnings & Events
      Earnings Calls
      Last call
      Aug 11, 2026
      View

      Performance

      5D 20D 120D MTD YTD
      STXS -2.8% -11.0% -35.5% +9.5% -40.0%
      SPY +0.4% +4.5% +13.8% +3.9% +13.9%
      vs SPY -3.2% -15.4% -49.3% +5.6% -53.9%
      Key facts CIK 1289340 CUSIP 85916J409 13F (30d) 104 filings 104 filers Visit website Investor relations